Clinical Study
Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
Table 5
Total AUC values in patients receiving exenatide and liraglutide on visits 1 and 2.
| | Parameters | Exenatide | Liraglutide | |
| | First visit | | | | | Triglycerides (mmol/L·min) | | | 0.290 | | Total cholesterol (mmol/L·min) | | | 0.140 | | HDL (mmol/L·min) | | | 0.306 | | LDL (mmol/L·min) | | | 0.472 | | Glucose (mmol/L·min) | | | 0.364 | | Insulin (pmol/L·min) | | | 0.151 | | Second visit | | | | | Triglycerides (mmol/L·min) | | | 0.307 | | Total cholesterol (mmol/L·min) | | | 0.850 | | HDL (mmol/L·min) | | | 0.305 | | LDL (mmol/L·min) | | | 0.089 | | Glucose (mmol/L·min) | | | 0.762 | | Insulin (pmol/L·min) | | | 0.174 |
|
|
Data are means ± SD. indicates the result of the Mann-Whitney test.
|
